| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.22 | 7e-07 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.19 | 4e-06 |
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.15 | 3e-05 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.16 | 7e-05 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0002 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.2 | 0.0003 |